MENU Quick Go

  • HOME
  • News
  • PharmAbcine Notice
PharmAbcine Notice
Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a keynote presentation at Asia Pharma R&D Leaders Summit 2018 on April 17-18, 2018.
Date 2018-03-25 Hit 255
Attach Files  

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a keynote presentation at Asia Pharma R&D Leaders Summit 2018 on April 17-18, 2018 (http://aprdl2018.com/speaker.html).


Event: Asia Pharma R&D Leaders Summit 2018

Keynote :  Clinical Development of Tanibirumab, Its IO combination and novel IO program
                     -- Tanibirumab in recurrent GBM phase IIa open labelled three arms multi-center trial in Australia
                     -- Rationale of Tanibirumab + anti-PD1 antibody combination trials for refractory tumous
                     -- Development of novel IO bispecific antibody


Presentation Date: Tuesday, April 18th, 2018
Presentation Time: 10:00 - 10:30 AM
Location: InterContinental Shanghai Pudong Hotel, CHINA


For investors attending the Asia Pharma R&D Leaders Summit 2018, please contact PharmAbcine Investor Relations to schedule a meeting with management at sungwoo.kim@pharmabcine.com.

List